Peptide Therapeutics Market is expected to reach US$ 50,003.15 million in 2027

Published Date: 22 Feb 2021

Report : Peptide Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Generic and Innovative), Route of Administration (Parenteral, Oral, Mucosal, Pulmonary, and Others), Synthesis Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), and Hybrid Technology), and Application (Cancer, Cardiovascular Disorder, Metabolic Disorder, Respiratory Disorder, Pain, and Dermatology), and Geography

Generic Segment to Grow at Faster Pace during Forecast Period

 

According to our new research study on “Peptide Therapeutics Market Forecast to 2027 – COVID-19 Impact and Analysis – by Type, Route of Administration, Synthesis Technology, and Application,” the peptide therapeutics market is expected to reach US$ 50,003.15 million by 2027 from US$ 24,878.55 million in 2019; it is estimated to grow at a CAGR of 9.2% from 2020 to 2027. The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The growth of the peptide therapeutics market is mainly attributed to the growing investments on peptide therapeutics and increasing prevalence of metabolic disorders and infectious diseases. However, operational limitations of peptides deter the market growth.

 

On the basis of type, the peptide therapeutics market is segmented into innovative and generic. The innovative segment held a larger share of the market in 2019; however, the generic segment is expected to register a higher CAGR during the forecast period. Rising number of research collaborations amongst market players are estimated to offer favorable environment for growth of generic segment.

 

Increasing utilization of peptide molecules for the development of COVID-19 vaccine is estimated to have a positive impact on the market growth. Moreover, extensive support from government authorities for the use of peptides for COVID-19 vaccine development is also anticipated to offer potential opportunity for the adoption of peptides, which will eventually accelerate the growth of peptide therapeutics market. 

 

Eli Lilly and Company, Amgen Inc., TEVA PHARMACEUTICAL INDUSTRIES LTD, Polypeptide Group, EVER Pharma GmbH, Bristol-Myers Squibb Company, Novo Nordisk A/S, Sanofi, AstraZeneca PLC, and Glaxosmithkline PLC are among the leading companies operating in the peptide therapeutics market.  

 

Peptide Therapeutics Market, by Region, 2019 (%) 

Peptide Therapeutics Market, by Region, 2019 (%) 

 

The report segments peptide therapeutics market as follows:

 

By Type

  • Innovative
  • Generic

By Route of Administration

  • Parenteral
  • Mucosal
  • Oral
  • Pulmonary
  • Others

By Synthesis Technology

  • Solid Phase Peptide Synthesis (SPPS)
  • Liquid Phase Peptide Synthesis (LPPS)
  • Hybrid Technology

By Application

  • Cancer
  • Metabolic Disorder
  • Cardiovascular Disorder
  • Respiratory Disorder
  • Pain
  • Dermatology

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of APAC
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of MEA
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

Contact Us

Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com    
Download PDF Brochure